These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21905036)

  • 1. Stability of human growth hormone in supercritical carbon dioxide.
    Kelly CA; Howdle SM; Naylor A; Coxhill G; Tye LC; Illum L; Lewis AL
    J Pharm Sci; 2012 Jan; 101(1):56-67. PubMed ID: 21905036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
    Jordan F; Naylor A; Kelly CA; Howdle SM; Lewis A; Illum L
    J Control Release; 2010 Jan; 141(2):153-60. PubMed ID: 19772878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel.
    Park MR; Chun C; Ahn SW; Ki MH; Cho CS; Song SC
    J Control Release; 2010 Nov; 147(3):359-67. PubMed ID: 20713099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering.
    Davies OR; Lewis AL; Whitaker MJ; Tai H; Shakesheff KM; Howdle SM
    Adv Drug Deliv Rev; 2008 Feb; 60(3):373-87. PubMed ID: 18069079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supercritical fluids processing of recombinant human growth hormone.
    Velega SP; Carlfors J
    Drug Dev Ind Pharm; 2005 Jan; 31(2):135-49. PubMed ID: 15773281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of methionine oxidation on the aggregation of recombinant human growth hormone.
    Mulinacci F; Poirier E; Capelle MA; Gurny R; Arvinte T
    Eur J Pharm Biopharm; 2013 Sep; 85(1):42-52. PubMed ID: 23958317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and in vivo study of sustained-release formulation of human growth hormone using sodium hyaluronate.
    Hahn SK; Kim SJ; Kim MJ; Kim DH
    Pharm Res; 2004 Aug; 21(8):1374-81. PubMed ID: 15359571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thermal and mechanical stress on the physical stability of human growth hormone and epidermal growth factor.
    Lim JY; Kim NA; Lim DG; Kim KH; Jeong SH
    Arch Pharm Res; 2015 Aug; 38(8):1488-98. PubMed ID: 25430693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size prediction of recombinant human growth hormone nanoparticles produced by supercritical fluid precipitation.
    Pyo D; Lim C; Cho D; Oh D
    Anal Bioanal Chem; 2007 Feb; 387(3):901-7. PubMed ID: 17186228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering liposomes of leaf extract of seabuckthorn (SBT) by supercritical carbon dioxide (SCCO2)-mediated process.
    Ghatnur SM; Sonale RS; Balaraman M; Kadimi US
    J Liposome Res; 2012 Sep; 22(3):215-23. PubMed ID: 22397357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of niosomes prepared by supercritical carbon dioxide (scCO2) fluid.
    Manosroi A; Chutoprapat R; Abe M; Manosroi J
    Int J Pharm; 2008 Mar; 352(1-2):248-55. PubMed ID: 18036754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formation.
    Moribe K; Tozuka Y; Yamamoto K
    Adv Drug Deliv Rev; 2008 Feb; 60(3):328-38. PubMed ID: 18006109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-native intermediate conformational states of human growth hormone in the presence of organic solvents.
    Sukumar M; Storms SM; De Felippis MR
    Pharm Res; 2005 May; 22(5):789-96. PubMed ID: 15906175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized recombinant human growth hormone that maintains conformational integrity.
    Mulinacci F; Bell SE; Capelle MA; Gurny R; Arvinte T
    J Pharm Sci; 2011 Jan; 100(1):110-22. PubMed ID: 20575051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructure controlled sustained delivery of human growth hormone using injectable, biodegradable, pH/temperature responsive nanobiohybrid hydrogel.
    Singh NK; Nguyen QV; Kim BS; Lee DS
    Nanoscale; 2015 Feb; 7(7):3043-54. PubMed ID: 25603888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of protamine on the solubility and deamidation of human growth hormone.
    Ablinger E; Wegscheider S; Keller W; Prassl R; Zimmer A
    Int J Pharm; 2012 May; 427(2):209-16. PubMed ID: 22342332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel method for the production of crystalline micronised particles.
    Muhammad SA; Langrish T; Tang P; Adi H; Chan HK; Kazarian SG; Dehghani F
    Int J Pharm; 2010 Mar; 388(1-2):114-22. PubMed ID: 20043982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Stability of Recombinant Human Growth Hormone (r-hGH) as a Function of Polymer Surface Properties.
    Shah VR; Gupta PK
    Pharm Res; 2018 Mar; 35(5):98. PubMed ID: 29546461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of bioactive recombinant human growth hormone from PLGA microparticles.
    Rafi M; Singh SM; Kanchan V; Anish CK; Panda AK
    J Microencapsul; 2010; 27(6):552-60. PubMed ID: 20690791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.